LIVE: The WHO and BioNTech give an update on mRNA vaccine for malaria
Reuters, 26 Jul 2021
BioNTech officials speak on the development of the first mRNA-based vaccine for malaria prevention with the initiation of a clinical trial by the end of 2022, followed by a presser with the WHO and EU’s Ursula von der Leyen